Ion Exchange

Ion Exchange (India) Limited reported operating income of INR 7,339 million for Q2 FY26, marking a 14% year-on-year increase. The company's EBITDA stood at INR 685 million with margins at 9.33%, while net profit was INR 499 million, declining 1.4% year-on-year. For the first half of FY26, operating income reached INR 13,171 million, up 9% year-on-year, with net profit of INR 984 million growing 3%. The engineering division recorded revenue of INR 4,562 million (16% growth) but segment EBIT declined 5% to INR 224 million due to legacy project impacts and elevated infrastructure costs. The chemicals segment showed strong performance with revenue of INR 2,184 million (11% growth) and EBIT of INR 591 million (13% growth). The consumer products division achieved INR 858 million revenue (24% growth) while reducing losses. The company commenced stage-wise commissioning of its greenfield manufacturing plant at Roha, Maharashtra in September 2025, with total CAPEX of approximately Rs 450 crores. Ion Exchange also entered a strategic partnership with MANN+HUMMEL Water Membrane Solutions for manufacturing advanced membranes in India. The current order book stands at INR 27,110 million with order inflow of INR 4,700 million during the quarter.

Ion Exchange (India) Limited reported consolidated operating income of INR 7,339 million for Q2 FY26, marking a 31% year-over-year increase from INR 5,832 million. However, operating EBITDA margins declined to 9.33% from 10.75% in the previous year. Net profit reached INR 499 million with diluted EPS of INR 4.178 per share. For the half-year period, consolidated revenue grew 8.7% to INR 13,171 million with net profit of INR 984 million. The company completed migration to SAP environment and commenced stage-wise commissioning of its greenfield resin manufacturing plant at Roha, Maharashtra. Engineering segment showed sequential improvement in order flow driven by medium-sized opportunities, while the services division recorded strong growth through acquisition of high-value long-term O&M contracts. The company entered a strategic partnership with MANN+HUMMEL Water & Membrane Solutions for local membrane manufacturing. Engineering order book stands at INR 9,011 crores as of September 30, 2025.

Ion Exchange is targeting an order book exceeding ₹2,500 crores, focusing on industrial and municipal water treatment projects. The company is emphasizing exports, desalination, and zero-liquid-discharge systems as key growth areas. Ion Exchange is investing in research and development along with membrane manufacturing to expand its sustainable water-tech solutions and strengthen its global presence.